Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa.

Metcalf CJ, Cohen C, Lessler J, McAnerney JM, Ntshoe GM, Puren A, Klepac P, Tatem A, Grenfell BT, Bjørnstad ON.

J R Soc Interface. 2013 Jan 6;10(78):20120756. doi: 10.1098/rsif.2012.0756.

2.

Balancing evidence and uncertainty when considering rubella vaccine introduction.

Lessler J, Metcalf CJ.

PLoS One. 2013 Jul 5;8(7):e67639. doi: 10.1371/journal.pone.0067639.

3.

Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination.

Metcalf CJ, Lessler J, Klepac P, Cutts F, Grenfell BT.

Epidemiol Infect. 2012 Dec;140(12):2290-301. doi: 10.1017/S0950268812000131.

4.

Congenital rubella syndrome: a matter of concern.

Martínez-Quintana E, Castillo-Solórzano C, Torner N, Rodríguez-González F.

Rev Panam Salud Publica. 2015 Mar;37(3):179-86. Review.

5.

Modelling the incidence of congenital rubella syndrome in developing countries.

Cutts FT, Vynnycky E.

Int J Epidemiol. 1999 Dec;28(6):1176-84.

PMID:
10661666
6.

Rubella metapopulation dynamics and importance of spatial coupling to the risk of congenital rubella syndrome in Peru.

Metcalf CJ, Munayco CV, Chowell G, Grenfell BT, Bjørnstad ON.

J R Soc Interface. 2011 Mar 6;8(56):369-76. doi: 10.1098/rsif.2010.0320.

7.

Introduction of rubella-containing-vaccine to Madagascar: implications for roll-out and local elimination.

Wesolowski A, Mensah K, Brook CE, Andrianjafimasy M, Winter A, Buckee CO, Razafindratsimandresy R, Tatem AJ, Heraud JM, Metcalf CJ.

J R Soc Interface. 2016 Apr;13(117). pii: 20151101. doi: 10.1098/rsif.2015.1101.

8.
9.

Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005.

Muller CP, Kremer JR, Best JM, Dourado I, Triki H, Reef S; WHO Steering Committee for Measles and Rubella..

Vaccine. 2007 Jan 2;25(1):1-9.

PMID:
17262908
10.

The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome.

Vynnycky E, Gay NJ, Cutts FT.

Vaccine. 2003 Jun 20;21(21-22):2708-19.

PMID:
12798608
11.

Progress in Italy in control and elimination of measles and congenital rubella.

Bonanni P, Bechini A, Boccalini S, Peruzzi M, Tiscione E, Boncompagni G, Mannelli F, Salmaso S, Filia A, Ciofi degli Atti M.

Vaccine. 2007 Apr 20;25(16):3105-10.

PMID:
17306425
12.

Congenital rubella still a public health problem in Italy: analysis of national surveillance data from 2005 to 2013.

Giambi C, Filia A, Rota MC, Del Manso M, Declich S, Nacca G, Rizzuto E, Bella A; regional contact points for rubella..

Euro Surveill. 2015 Apr 23;20(16). pii: 21103.

13.

Rubella vaccine: new horizon in prevention of congenital rubella syndrome in the India.

Verma R, Khanna P, Chawla S.

Hum Vaccin Immunother. 2012 Jun;8(6):831-3. doi: 10.4161/hv.19584.

PMID:
22495120
14.

Targeting rubella for elimination.

Taneja DK, Sharma P.

Indian J Public Health. 2012 Oct-Dec;56(4):269-72. doi: 10.4103/0019-557X.106413. Review.

15.

Burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001.

Lanzieri TM, Segatto TC, Siqueira MM, de Oliviera Santos EC, Jin L, Prevots DR.

Pediatr Infect Dis J. 2003 Apr;22(4):323-9.

PMID:
12690271
16.

Rubella vaccination and congenital rubella syndrome in Western Australia.

Condon RJ, Bower C.

Med J Aust. 1993 Mar 15;158(6):379-82.

PMID:
8479351
17.

A resurgence of congenital rubella in Australia?

Forrest JM, Burgess M, Donovan T.

Commun Dis Intell Q Rep. 2003;27(4):533-6.

18.

Global Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - 2000-2014.

Grant GB, Reef SE, Dabbagh A, Gacic-Dobo M, Strebel PM.

MMWR Morb Mortal Wkly Rep. 2015 Sep 25;64(37):1052-5. doi: 10.15585/mmwr.mm6437a5.

19.

Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience.

Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, Reef SE, Redd SB, Abernathy ES, Barskey AE, Hao L, McLean HQ, Rota JS, Bellini WJ, Seward JF.

JAMA Pediatr. 2014 Feb;168(2):148-55. doi: 10.1001/jamapediatrics.2013.4342.

PMID:
24311021
20.

Health economics of rubella: a systematic review to assess the value of rubella vaccination.

Babigumira JB, Morgan I, Levin A.

BMC Public Health. 2013 Apr 29;13:406. doi: 10.1186/1471-2458-13-406. Review.

Items per page

Supplemental Content

Support Center